Therapy Areas: Oncology
EUSA Pharma Names Rolf K Hoffmann to Board of Directors
9 March 2018 - - Hemel Hempstead, England-based specialty pharmaceutical company EUSA Pharma has appointed Rolf K Hoffmann to its board of directors, the company said.
Hoffmann is currently chairman of Biotest AG, sits on the board of directors of European biotechnology company Genmab AG, and is a director of San Francisco-based Trigemina Inc.
He has served in a number of senior roles in the pharmaceutical industry, most recently 12 years with Amgen as senior vice president of commercial operations for the US, and before that for SVP International and Europe.
He started his pharmaceutical career at Eli Lilly as a sales representative, and progressed to a number of senior positions, including president, Latin America and general manager in Germany and South Africa.
Hoffman holds an MBA from the University of North Carolina, a Master's degree from the University of Cologne, and is Adjunct Professor at UNC Kenan-Flagler Business School.
EUSA Pharma focuses on oncology and oncology supportive care. The company has commercial operations in the US and Europe, and a wider distribution network in approximately 40 countries around the world.


Related Headlines